93 related articles for article (PubMed ID: 1949975)
1. Sertraline: a new specific serotonin reuptake blocker.
Guthrie SK
DICP; 1991 Sep; 25(9):952-61. PubMed ID: 1949975
[TBL] [Abstract][Full Text] [Related]
2. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.
Murdoch D; McTavish D
Drugs; 1992 Oct; 44(4):604-24. PubMed ID: 1281075
[TBL] [Abstract][Full Text] [Related]
3. Sertraline: a new antidepressant.
Doogan DP; Caillard V
J Clin Psychiatry; 1988 Aug; 49 Suppl():46-51. PubMed ID: 2842321
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of sertraline: a review.
Heym J; Koe BK
J Clin Psychiatry; 1988 Aug; 49 Suppl():40-5. PubMed ID: 3045112
[TBL] [Abstract][Full Text] [Related]
5. The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.
Tulloch IF; Johnson AM
J Clin Psychiatry; 1992 Feb; 53 Suppl():7-12. PubMed ID: 1531829
[TBL] [Abstract][Full Text] [Related]
6. Clinical overview of serotonin reuptake inhibitors.
Rickels K; Schweizer E
J Clin Psychiatry; 1990 Dec; 51 Suppl B():9-12. PubMed ID: 2147922
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of sertraline, amitriptyline, and placebo on the psychomotor performance of healthy subjects over 50 years of age.
Mattila MJ; Saarialho-Kere U; Mattila M
J Clin Psychiatry; 1988 Aug; 49 Suppl():52-8. PubMed ID: 3045113
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the selective serotonin reuptake inhibitors.
DeVane CL
J Clin Psychiatry; 1992 Feb; 53 Suppl():13-20. PubMed ID: 1531816
[TBL] [Abstract][Full Text] [Related]
9. Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake.
Koe BK
J Clin Psychiatry; 1990 Dec; 51 Suppl B():13-7. PubMed ID: 2175308
[TBL] [Abstract][Full Text] [Related]
10. The role of sertraline in the management of depression.
Shelton RC
Clin Ther; 1994; 16(5):768-82; discussion 767. PubMed ID: 7859236
[TBL] [Abstract][Full Text] [Related]
11. Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo.
Jenike MA; Baer L; Summergrad P; Minichiello WE; Holland A; Seymour R
Am J Psychiatry; 1990 Jul; 147(7):923-8. PubMed ID: 2192564
[TBL] [Abstract][Full Text] [Related]
12. The effects of sertraline on psychomotor performance in elderly volunteers.
Hindmarch I; Shillingford J; Shillingford C
J Clin Psychiatry; 1990 Dec; 51 Suppl B():34-6. PubMed ID: 2258380
[TBL] [Abstract][Full Text] [Related]
13. Sertraline and cocaine-induced locomotion in mice. I. Acute studies.
Reith ME; Wiener HL; Fischette CT
Psychopharmacology (Berl); 1991; 103(3):297-305. PubMed ID: 2057535
[TBL] [Abstract][Full Text] [Related]
14. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.
Chouinard G; Goodman W; Greist J; Jenike M; Rasmussen S; White K; Hackett E; Gaffney M; Bick PA
Psychopharmacol Bull; 1990; 26(3):279-84. PubMed ID: 2274626
[TBL] [Abstract][Full Text] [Related]
15. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J
Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
[TBL] [Abstract][Full Text] [Related]
16. [The clinicopharmacological case (5). serotonin reuptake inhibitor and 5-HT3-receptor antagonists: are there clinically relevant interactions?].
Kind B; Fattinger K; Krähenbühl S; Meier-Abt PJ
Praxis (Bern 1994); 1996 Nov; 85(46):1490-2. PubMed ID: 8984572
[TBL] [Abstract][Full Text] [Related]
17. Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy.
Alderman J; Wolkow R; Chung M; Johnston HF
J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):386-94. PubMed ID: 9549959
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of the pharmacology of sertraline.
Warrington SJ
Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 2():11-21. PubMed ID: 1806626
[TBL] [Abstract][Full Text] [Related]
19. Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.
Fineberg NA; Bullock T; Montgomery DB; Montgomery SA
Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():43-7. PubMed ID: 1517558
[No Abstract] [Full Text] [Related]
20. Selective serotonin reuptake inhibitors in OCD.
Montgomery SA; Bullock T; Fineberg N; Montgomery D
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():255A-256A. PubMed ID: 1498831
[No Abstract] [Full Text] [Related]
[Next] [New Search]
